IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pathway Capital Management, LP

Q4 2020 Holdings

Filed 2021-02-10 | 2 holdings | $1.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mersana Therapeutics IncCOM59045L106$1.1K40,60084.4%
Quanterix Corp(QTRX)COM74766Q101$2004,30015.6%